Donthineni Linga Rao's Insider Trades & SAST Disclosures
Donthineni Linga Rao's most recent trade in Natco Pharma Ltd. was a Disposal of 10,000 Equity Shares done at an average price of Rs. 800.0 . Disclosure was reported to the exchange on Dec. 29, 2023 under the SEBI (Prohibition of Insider Trading) Regulations, 2015.
No reported SAST transactions available for Donthineni Linga Rao in the Trendlyne database.
| Stock | Client Name | Client Category | Action* | Reported To/By Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Period | Regulation (Insider/SAST) | Security Type | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Natco Pharma | LINGA RAO DONTHINENI | Director | Disposal | 29 Dec 2023 | 10,000 | 54,155 (0.03%) | 0.01% | 800.0 | 7,999,859 | 28 Dec 2023 28 Dec 2023 |
Insider Trading | Equity Shares | Market Sale |
| Natco Pharma | Dr. LINGA RAO DONTHINENI | Director | Acquisition | 28 Sep 2020 | 7,500 | 64,155 (0.03%) | 0.00% | 2 | 15,000 | 28 Sep 2020 28 Sep 2020 |
Insider Trading | Equity Shares | ESOP |
Acquisition (Buy): Purchase of shares
Disposal (Sell): Sale of shares
Pledge: Shares being used by promoters as collateral for loans. Usually a negative signal.
Revoke: When shares are released from a pledge. Usually a positive signal.
Invoke: When pledged shares are invoked by companies/banks who have provided the collateral, which may result in acquisition of stake in the company. Usually a negative signal.
Security Type: Share/ Warrants / Convertible Debentures
Kind of transaction Mode: Public rights/ preferential offer / off market / inter-se transfer/ Market Sale
Data as reported to BSE and NSE
Insider trading data is from Disclosure under SEBI (Prohibition of Insider Trading) Regulations, 2015.